Lilan I. Zhao
134 East Street
Fuzhou, 350001, China
Fuzhou, 350001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Serum FAP⁺ exosome-based flow cytometric detection: potential utility in early diagnosis, disease progression assessment, and surgical response monitoring of lung adenocarcinoma.
Journal: Journal of nanobiotechnology
Published: March 16, 2026
Risk of drug-related aggression in pediatric populations: a pharmacovigilance analysis using the FAERS database.
Journal: Frontiers in pediatrics
Published: February 03, 2026
GPRC5A+ myCAFs promote ESCC progression via TGF-β-induced fibroblast activation and ANXA1-mediated M2 macrophage polarization.
Journal: International immunopharmacology
Published: August 13, 2025
Comparative performance evaluation of large language models in answering esophageal cancer-related questions: a multi-model assessment study.
Journal: Frontiers in digital health
Published: July 21, 2025
Favorable outcomes with jejunal interposition without vascular anastomosis for esophagectomy in cancer patients: a single-center experience.
Journal: BMC surgery
Published: March 06, 2025
Efficacy and safety of neoadjuvant camrelizumab and apatinib combined with chemotherapy in stage IIIA (N2) NSCLC: a multi-center, single-arm, phase II trial.
Journal: BMC medicine
Published: December 31, 2024
Development a glycosylated extracellular vesicle-derived miRNA Signature for early detection of esophageal squamous cell carcinoma.
Journal: BMC medicine
Published: July 13, 2024
Pyroptosis-related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma.
Journal: Molecular carcinogenesis
Published: April 10, 2024
Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 19, 2023
CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis.
Journal: Oncoimmunology
Published: October 25, 2023
Last Updated: 09/26/2026